MHC molecules are critical for the immune system to recognize and target cancer cells. Tumor cells can express abnormal antigens known as tumor-associated antigens (TAAs) or neoantigens. These antigens are processed and presented by MHC molecules to T cells, which can then initiate an immune response to eliminate the cancer cells.
